Community-Acquired Acute Kidney Injury Induced By Drugs In Older Patients: A Multifactorial Event

References

• Soto K, Campos P, Pinto I, et al. The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury. Kidney Int. 2016;90(5):1090–1099. doi:10.1016/j.kint.2016.07.01827658322
   PubMed Web of Science ®Google Scholar
• Stucker F, Ponte B, De la Fuente V, et al. Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study. BMC Nephrol. 2017;18:1. doi:10.1186/s12882-017-0792-228049448
   PubMed Web of Science ®Google Scholar
• Hazara AM, Elgaali M, Naudeer S, Holding S, Bhandari S. The use of automated electronic alerts in studying short-term outcomes associated with community-acquired acute kidney injury. Nephron. 2017;135(3):181–188. doi:10.1159/00045477928030861
   PubMed Web of Science ®Google Scholar
• Talabani B, Zouwail S, Pyart RD, Meran S, Riley SG, Phillips AO. Epidemiology and outcome of community-acquired acute kidney injury. Nephrology. 2014;19(5):282–287. doi:10.1111/nep.1222124571827
   PubMed Web of Science ®Google Scholar
• Emmett L, Tollitt J, McCorkindale S, Sinha S, Poulikakos D. The evidence of acute kidney injury in the community and for primary care interventions. Nephron. 2017;136(3):202–210. doi:10.1159/00046026628343224
   PubMed Web of Science ®Google Scholar
• Rosner MH. Acute kidney injury in the elderly. Clin Geriatr Med. 2013;29(3):565–578. doi:10.1016/j.cger.2013.05.00123849008
   PubMed Web of Science ®Google Scholar
• Forni LG, Dawes T, Sinclair H, et al. Identifying the patient at risk of acute kidney injury: a predictive scoring system for the development of acute kidney injury in acute medical patients. Nephron Clin Pract. 2013;123(3–4):143–150. doi:10.1159/00035150923887252
   PubMedGoogle Scholar
• Anderson S, Eldadah B, Halter JB, et al. Acute kidney injury in older adults. J Am Soc Nephrol. 2011;22(1):28–38. doi:10.1681/ASN.201009093421209252
   PubMed Web of Science ®Google Scholar
• Coca SG. Acute kidney injury in elderly persons. Am J Kidney Dis Off J Natl Kidney Found. 2010;56(1):122–131. doi:10.1053/j.ajkd.2009.12.034
   PubMed Web of Science ®Google Scholar
• O’Connor MN, Gallagher P, Byrne S, O’Mahony D. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing. 2012;41(6):771–776. doi:10.1093/ageing/afs04622456465
   PubMed Web of Science ®Google Scholar
• De Figueiredo TP, De Souza G, Barroso SCC, do N, Reis AMM. Factors associated with adverse drug reactions in older inpatients in teaching hospital. Int J Clin Pharm. 2017;39(4):679–685. doi:10.1007/s11096-017-0473-z28466398
   PubMed Web of Science ®Google Scholar
• Pierson-Marchandise M, Gras V, Moragny J, et al. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database. Br J Clin Pharmacol. 2017;83(6):1341–1349. doi:10.1111/bcp.1321628002877
   PubMed Web of Science ®Google Scholar
• Koza Y. Acute kidney injury: current concepts and new insights. J Inj Violence Res. 2016;8(1):58.26804946
   PubMedGoogle Scholar
• Schissler MM, Zaidi S, Kumar H, Deo D, Brier ME, McLeish KR. Characteristics and outcomes in community-acquired versus hospital-acquired acute kidney injury. Nephrology. 2013;18(3):183–187. doi:10.1111/nep.1203623336108
   PubMed Web of Science ®Google Scholar
• Wonnacott A, Meran S, Amphlett B, Talabani B, Phillips A. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clin J Am Soc Nephrol. 2014;9(6):1007–1014. doi:10.2215/CJN.0792071324677557
   PubMed Web of Science ®Google Scholar
• Hsu C-N, Lee C-T, Su C-H, et al. Incidence, outcomes, and risk factors of community-acquired and hospital-acquired acute kidney injury: a retrospective cohort study. Medicine (Baltimore). 2016;95(19):e3674. doi:10.1097/MD.000000000000367427175701
   PubMed Web of Science ®Google Scholar
• Mesropian PD, Othersen J, Mason D, Wang J, Asif A, Mathew RO. Community-acquired acute kidney injury: A challenge and opportunity for primary care in kidney health. Nephrol Carlton Vic. 2016;21(9):729–735. doi:10.1111/nep.12751
   Web of Science ®Google Scholar
• Wang Y, Wang J, Su T, et al. Community-acquired acute kidney injury: a nationwide survey in China. Am J Kidney Dis. 2017;69(5):647–657. doi:10.1053/j.ajkd.2016.10.03428117208
   PubMed Web of Science ®Google Scholar
• Finlay S, Bray B, Lewington AJ, et al. Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clin Med. 2013;13(3):233–238. doi:10.7861/clinmedicine.13-3-233
   PubMed Web of Science ®Google Scholar
• Chang Y-P, Huang S-K, Tao P, Chien C-W. A population-based study on the association between acute renal failure (ARF) and the duration of polypharmacy. BMC Nephrol. 2012;13:96. doi:10.1186/1471-2369-13-9622935542
   PubMed Web of Science ®Google Scholar
• Gong Y, Zhang F, Ding F, Gu Y. Elderly patients with acute kidney injury (AKI): clinical features and risk factors for mortality. Arch Gerontol Geriatr. 2012;54(2):e47–e51. doi:10.1016/j.archger.2011.05.01121684023
   PubMed Web of Science ®Google Scholar
• Loboz KK, Shenfield GM. Drug combinations and impaired renal function–the ‘triple whammy.’. Br J Clin Pharmacol. 2005;59(2):239–243. doi:10.1111/j.1365-2125.2004.02188.x15676048
   PubMed Web of Science ®Google Scholar
• WHO International Classification of Diseases. WHO International Classification of Diseases. Available from: http://www.who.int/classifications/icd/en/ Accessed 1021, 2019.
   Google Scholar
• WHO The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). WHO The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Available from: http://www.who.int/classifications/atcddd/en/ Accessed 36, 2018.
   Google Scholar
• IUPAC | International Union of Pure and Applied Chemistry. International Union of Pure and Applied Chemistry. Available from: https://iupac.org/ Accessed 36, 2018.
   Google Scholar
• Chazard E, Mouret C, Ficheur G, Schaffar A, Beuscart J-B, Beuscart R. Proposal and evaluation of FASDIM, a fast and simple de-identification method for unstructured free-text clinical records. Int J Med Inf. 2014;83(4):303–312. doi:10.1016/j.ijmedinf.2013.11.005
   Web of Science ®Google Scholar
• Chazard E, Băceanu A, Ferret L, Ficheur G. The ADE scorecards: a tool for adverse drug event detection in electronic health records. Stud Health Technol Inf. 2011;166:169–179.
   Google Scholar
• Beuscart R, Hackl W, Nøhr C. Detection and prevention of adverse drug events - information technologies and human factors. Preface Stud Health Technol Inform. 2009;148:v–vi.19745253
   PubMedGoogle Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-0000619414839
   PubMed Web of Science ®Google Scholar
• Matsushita K, Mahmoodi BK, Woodward M. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012. doi:10.1001/jama.2012.3954
   Web of Science ®Google Scholar
• Whiting P, Morden A, Tomlinson LA, et al. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open. 2017;7(4):e012674. doi:10.1136/bmjopen-2016-012674
   Web of Science ®Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.1547249508
   PubMed Web of Science ®Google Scholar
• Khan LM, Al-Harthi SE, Osman A-M-M, Sattar MAAA, Ali AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2016;24(4):485–493. doi:10.1016/j.jsps.2015.01.010
   PubMed Web of Science ®Google Scholar
• Agbabiaka TB, Savović J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf. 2008;31(1):21–37. doi:10.2165/00002018-200831010-0000318095744
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44(2):213–218. doi:10.1093/ageing/afu14525324330
   PubMed Web of Science ®Google Scholar
• Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90. doi:10.1111/j.1365-2796.1990.tb00199.x2394974
   PubMed Web of Science ®Google Scholar
• Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7(1):11–22. doi:10.1177/204209861561547226834959
   PubMed Web of Science ®Google Scholar
• Morrison C, Wilson DM MEDICINE SICK DAY RULES CARDS – UPDATE TO EVALUATION.:3.
   Google Scholar
• Belaiche S, Romanet T, Allenet B, Calop J, Zaoui P. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. J Nephrol. 2012;25(5):782–788. doi:10.5301/jn.500006322322820
   PubMed Web of Science ®Google Scholar
• Belaiche S, Mercier E, Cuny D, et al. Community pharmacists’ interventions to prevent and screen chronic kidney disease patients. Nephrol Ther. 2017;13(2):87–92. doi:10.1016/j.nephro.2016.06.00627810277
   PubMed Web of Science ®Google Scholar
• Shalayel MH, Mohamed Ayed IA, Huneif MA, Mohammed Kordofani Y. A retrospective evaluation of cutaneous adverse drug reactions (CADRs) due to antibiotics using naranjo adverse drug reactions (ADRs) probability scale. J Young Pharm. 2018;10(1):113–116. doi:10.5530/jyp.2018.10.25
   Web of Science ®Google Scholar
• Mittal N, Gupta MC. Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools. J Pharmacol Pharmacother. 2015;6(2):91–93. doi:10.4103/0976-500X.15548625969656
   PubMedGoogle Scholar